As­traZeneca stops lung can­cer tri­al ear­ly, af­ter star drug Tagris­so in­duces 'over­whelm­ing' ef­fi­ca­cy

A piv­otal lung can­cer tri­al test­ing Tagris­so, As­traZeneca’s best­selling on­col­o­gy ther­a­py, has been halt­ed due to “over­whelm­ing” ef­fi­ca­cy.

The 682 pa­tient-tri­al, ADAU­RA, was eval­u­at­ing the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER